source
- Veradermics' oral minoxidil clears late-stage trial endpointsVeradermics, a Connecticut‑based biotech, reported that its oral extended‑release formulation of minoxidil, VDPHL01, has completed a late‑stage clinical trial. The drug is a pill version of the wel…
- TriGemX Bio to go public via SPAC to advance migraine drug candidateTriGemX Bio, formerly known as Kallyope, said it will become a public company by merging with a special purpose acquisition company. The transaction is aimed at raising capital and accelerating the…